CASP1 and neoplasm: SPI-2 inhibits the proteolytic activity of IL-1β converting enzyme (ICE) (also known as caspase-1) [30], and deletion of SPI-2 has been used in our vvTD vector and such modification increases tumor targeting and reduces toxicity [17, 31].